Drugs / [11C]-PHNO
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06261905 Comparator | Mar 2024 → Feb 2025 | substance-related disorder | Yale University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]-PHNO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06261905 ↗ |
| Modality | Diagnostic / imaging agent | “PHNO is used as a tracer for in-vivo imaging.” NCT06261905 ↗ |